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INTRODUCTION
Acute interstitial pneumonia (AIP), a rapidly progressive re-
spiratory disease that affects patients with no pre-existing lung 
disease, is a lethal lung disease with a mortality rate of about 
50%.
1 Unclassified interstitial pneumonia with fibrosis, which is 
not classified as a disease entity under the classification of in-
terstitial lung diseases in adults,
1 shows clinical and radiologi-
cal findings that are similar with those of AIP. However, the 
pathological findings of unclassified interstitial pneumonia are 
different from those of AIP. AIP is characterized by histological 
findings of diffuse alveolar damage (DAD) in the acute phase 
with subsequent fibrotic organization, whereas unclassified in-
terstitial pneumonia with fibrosis is characterized histologically 
by centrilobular distribution of alveolar damage and bronchio-
lar destruction with bronchiolar obliteration. An increase in the 
incidence of unclassified interstitial pneumonia with fibrosis in 
Korean children was observed during March to June 2006.
2 This 
sudden increase in reported cases might have been the result of 
clinicians’ previous lack of awareness of the disease. Alterna-
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tively, it may indicate the occurrence of an epidemic.
3 In this re-
port, we describe two familial case series of unclassified inter-
stitial pneumonia with fibrosis, which developed almost simul-
taneously in the spring. These involved a previously healthy fa-
ther and son (Family 1), and a mother and two daughters (Fam-
ily 2).
CASE REPORTS
Family 1, Case 1
A previously healthy 2-year-old boy presented with a 1-month 
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Several children presenting with mild symptoms of respiratory tract infection were diagnosed with unclassified interstitial pneumonia with fibrosis. 
Their clinical and radiological findings were similar to those of acute interstitial pneumonia, but there were some differences in the pathological 
findings. Unclassified interstitial pneumonia with fibrosis is characterized by histological findings of centrilobular distribution of alveolar damage and 
bronchiolar destruction with bronchiolar obliteration. This report describes two different series of familial cases of unclassified interstitial pneumo-
nia with fibrosis, which developed almost simultaneously in the spring. Some of the individual cases showed rapidly progressive respiratory failure 
of unknown cause, with comparable clinical courses and similar radiological and pathological features, including lung fibrosis. Each family member 
was affected almost simultaneously in the spring, different kinds of viruses were detected in two patients, and all members were negative for bac-
terial infection, environmental and occupational agents, drugs, and radiation. These findings implicate a viral infection and/or processes related to a 
viral infection, such as an exaggerated or altered immune response, or an unknown inhaled environmental agent in the pathogenesis of unclassified 
interstitial pneumonia with fibrosis.
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history of cough and dyspnea. He had had a mild cough for 1 
week before a sudden deterioration in his condition. The dys-
pnea increased despite treatment, and he was transferred to 
the Department of Pediatrics at the Asan Medical Center for 
further management. On arrival, he was apyrexial and tachy-
pneic (respiratory rate, 66/min). Mild subcostal retraction was 
observed, and coarse breath sounds without crackles were not-
ed on auscultation. Arterial blood gas analysis (ABGA) showed 
mild hypoxemia. His white blood cell (WBC) count was 14,300/
μL, with 55.8% neutrophils and 36.3% lymphocytes. Radiogra-
phy and computed tomography (CT) of the chest revealed the 
presence of fine peribronchial ground-glass opacities in both 
lungs (Fig. 1A and 1B). Blood, bronchoalveolar lavage (BAL) 
fluid, and sputum cultures were negative for bacteria, viruses, 
and fungi. A lung biopsy performed on day 3 of admission 
showed the organizing phase of DAD distributed mainly in the 
centrilobular area, with destruction and obliteration of bron-
chioles by fibroblasts (Fig. 1E). The patient was administered 
intravenous corticosteroids (2 mg/kg/day), followed by oral 
prednisolone (which was gradually tapered), hydroxychloro-
quine, and oral cyclophosphamide. His condition gradually 
improved, although exercise intolerance persisted. At the 1-year 
follow-up, a repeat CT scan of the chest revealed a decrease in 
the extent of ground-glass opacities in the affected areas of both 
lungs (Fig. 1C and 1D).
Family 1, Case 2
A previously healthy 47-year-old non-smoking male patient 
presented with a 2-day history of cough, mucoid sputum, and 
chills. His son was hospitalized with the same symptoms at the 
same time. On physical examination, he was apyrexial, tachy-
cardic, and tachypneic, and rales were audible over the left lung 
field on auscultation. Chest radiography showed diffuse hazy 
patches in the left lung, and a chest CT scan revealed the pres-
ence of multifocal consolidation and diffuse centrinodular 
ground-glass opacities in both lungs. Laboratory findings in-
cluded a normal WBC count, an elevated erythrocyte sedimen-
tation rate (ESR) of 42 mm/hr, an elevated C-reactive protein 
(CRP) level of 5.19 mg/dL, and a normal ABGA. Laboratory 
tests for collagen disease and vasculitis were negative. Blood, 
sputum, and BAL fluid cultures were negative for bacteria, vi-
ruses, and fungi. Lung biopsy, performed on day 11 of admis-
sion, showed histological features of fibroproliferative DAD with 
diffuse interstitial fibrosis and relative sparing of the peripheral 
lobular air spaces. The patient required mechanical ventilation 
for a total of 36 days. He was administered broad-spectrum an-
tibiotics and high-dose corticosteroids. On discharge, he still 
experienced dyspnea on exertion and required intermittent ox-
ygen at night and on exertion. At the 1-year follow-up, radiogra-
phy and a CT scan revealed a decrease in the degree of bron-
chial dilatation and peribronchial consolidation; the patient 
still complained of dyspnea on exertion.
Family 2, Case 3
A previously healthy 35-month-old girl was referred to our 
medical center for severe dyspnea. Four weeks prior to admis-
sion, she had developed a mild cough, and her oral intake had 
become poor. Four days prior to admission, she had developed 
sudden onset dyspnea and subcutaneous emphysema. On ad-
mission, she presented with marked tachypnea (respiratory rate, 
80/min) and chest retraction, and rales were audible in both 
lungs on auscultation. Radiography and a CT scan of the chest 
showed an extensive pneumomediastinum, a pneumothorax 
in the right hemithorax, and diffuse ground-glass opacities with 
consolidation in both lungs (Fig. 2A and 2B). Her total leukocyte 
count was 9,300/μL, with 66% neutrophils and 27% lympho-
cytes. Blood, sputum, and BAL cultures for bacteria and fungi 
were negative. Multiplex RT-PCR of nasopharyngeal aspirates 
revealed the presence of respiratory syncytial virus (RSV). She 
was admitted to the intensive care unit and treated with steroids, 
cyclophosphamide, hydroxychloroquine, and broad-spectrum 
Fig. 1.  Chest radiography and biopsy specimens for Case 1. Chest radiography 
(A) on day 2 of the exacerbation of cough and dyspnea. Chest computed tomog-
raphy (CT) scan (B) on admission revealed the presence of ground-glass attenu-
ation with diffuse centrinodular opacity in both lungs. Pre-discharge chest radi-
ography (C) and chest CT (D) showed a reduction in the extent of ground-glass 
opacities in both lungs. Biopsy specimens (E) obtained on day 14 of the exacer-
bation of symptoms. Alveolar pneumocyte hyperplasia (arrow) and interstitial 
fibroblastic proliferation are features consistent with the organizing phase of 
diffuse alveolar damage. Bronchioles are destructed and obliterated by fibro-
blastic proliferation (asterisk). (Hematoxylin and eosin staining, ×200 magnifi-
cation)
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antibiotics. Her response to treatment was poor, and her condi-
tion deteriorated rapidly. On the third day of admission, me-
chanical ventilation was required for impending respiratory 
failure. Repeated chest radiography revealed the presence of 
increased opacities in both lungs (Fig. 2C). She then developed 
refractory hypoxemic and hypercarbic respiratory failure with 
subsequent multiorgan dysfunction. Despite the administra-
tion of antifibrotics and supportive therapy, she died 70 days af-
ter admission. A postmortem lung biopsy revealed the features 
of the fibrotic phase of DAD with occasional hyaline membrane 
and type II pneumocyte hyperplasia (Fig. 2D).
Family 2, Case 4
A 30-year-old non-smoking woman, who was the mother of 
Cases 3 and 5, was admitted to the Department of Internal Med-
icine at the Asan Medical Center with a 1-month history of cough 
and a 10-day history of dyspnea on exertion. On physical exam-
ination, she was apyrexial and tachypneic (respiratory rate, 44/
min), and crackles were audible over the right lung on auscul-
tation. No hypoxemia was detected by ABGA. Her leukocyte 
count was 14,000/μL, with 72% neutrophils and 20% lympho-
cytes. The ESR was 38 mm/hr; and the CRP was 1.92 mg/dL. 
Laboratory tests for collagen vascular disease and vasculitis 
Fig. 2.  Findings for Case 3. Chest radiography (A) and chest computed tomog-
raphy scan (B) revealed the presence of an extensive pneumomediastinum, a 
pneumothorax of the right lung, and diffuse ground-glass opacities and consoli-
dation in both lungs. Follow-up chest radiography on day 72 of admission re-
vealed an increased level of bilateral infiltrates (C). Histological section (D) ob-
tained from a postmortem biopsy showed extensive interstitial fibrosis with hy-
perplastic type II pneumocytes and hyaline membrane formation, suggesting 
the fibrotic phase of diffuse alveolar damage. Bronchiolar destruction and mild 
bronchiolar obliteration are present. (Hematoxylin and eosin staining, ×400 
magnification)
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were negative. Blood, sputum, and BAL fluid cultures were neg-
ative for bacteria, viruses, and fungi. Pulmonary function tests 
showed a mild restrictive defect. Radiography and a CT scan of 
the chest revealed the presence of multifocal patchy consolida-
tion with ground-glass opacities and tiny nodular lesions in 
both lungs. The patient was treated with steroid pulse therapy, 
followed by oral steroids, azathioprine, and antibiotics. The 
dyspnea gradually decreased, and she was discharged after 2 
weeks of treatment. A repeat CT scan of the chest 12 days post-
discharge showed an increase in the extent of ground-glass 
opacities and tiny nodules in both lungs. She was readmitted 14 
days post-discharge with increased dyspnea. Cyclosporine was 
added to her existing treatment regimen of steroids and azathi-
oprine. Transbronchial biopsy showed a nonspecific subacute 
lung injury pattern, including focal-organizing pneumonia and 
mild interstitial chronic inflammation. A follow-up chest CT 
scan 4 weeks after readmission revealed mild resolution of the 
abnormalities in both lungs. After discharge, her daily activities 
were limited by dyspnea, and she continued to experience dys-
pnea at rest.
Family 2, Case 5
A 17-month-old girl presented to the out-patient clinic at our 
medical center with a 30-day history of worsening cough. Her 
older sister (Case 3) had been admitted to the intensive care 
unit at the Asan Medical Center with respiratory failure 1 
month previously, and her mother (Case 4) had had similar 
symptoms during the previous 45 days. On physical examina-
tion, the patient was apyrexial, tachycardic, and tachypneic (re-
spiratory rate, 40/min). Her WBC count was 21,900/μL, with 
48% neutrophils and 43% lymphocytes. Blood, sputum, and 
BAL fluid cultures were negative for bacteria, viruses and fungi. 
However, multiplex RT-PCR of nasopharyngeal aspirates re-
vealed the presence of rhinovirus. Radiography and a CT scan 
of the chest showed the presence of centrilobular ground-glass 
opacities and septal thickening in both lungs. She was treated 
with steroids, cyclophosphamide, and hydroxychloroquine for 
2 weeks. She showed significant clinical improvement, and re-
peat chest radiography 2 weeks after the initiation of treatment 
revealed that the ground-glass opacities, septal thickening, and 
consolidation had decreased. After discharge, she did not re-
quire oxygen, and her daily activities were not restricted, al-
though she continued to experience dyspnea on exertion.
DISCUSSION
In this study, we described two series of familial cases of inter-
stitial lung disease of unknown etiology, in a young male patient 
and his father, and two young girls and their mother. They pre-
sented with the same clinical symptoms, showed rapidly pro-
gressive respiratory failure of unknown cause, and had similar 
radiological and pathological features, including rapidly pro-Unclassified Interstitial Pneumonia With Fibrosis
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gressive lung fibrosis. As this disease has not been previously 
described, we named this disease entity ‘unclassified intersti-
tial pneumonia with fibrosis.’ Previously, we reported this un-
classified interstitial pneumonia with rapidly progressive pul-
monary fibrosis as AIP.
2,3
AIP is a potentially fatal respiratory disease of unknown etiol-
ogy that presents in previously healthy individuals.
4-8 Unclassi-
fied interstitial pneumonia with fibrosis, which is not classified 
as any of the disease entities in the classification of interstitial 
lung diseases in adults,
1 shows clinical and radiological find-
ings that are similar to those of AIP. However, these two diseas-
es have different pathological findings. Unclassified interstitial 
pneumonia with fibrosis is characterized histologically by cen-
trilobular distribution of alveolar damage and bronchiolar de-
struction with bronchiolar obliteration.
This unclassified interstitial pneumonia with fibrosis com-
monly presents with an acute onset of cough and/or dyspnea 
in a previously healthy individual, similar to AIP.
4,8 Symptoms 
progress rapidly and may result in hypoxemia and cyanosis. 
Chest radiography in AIP reveals the presence of progressive 
airspace consolidation.
6,9 Chest CT scans in AIP reveal extensive 
bilateral airspace consolidation and patchy or diffuse ground-
glass attenuation.
6,9 In this report, we present two familial series 
of cases with unclassified interstitial pneumonia with fibrosis. 
The chest CT scans showed a pattern of consolidation predom-
inantly in the lower lungs, with subpleural sparing in the early 
phase. In the late phase, chest CT scans showed diffuse centri-
lobular nodular opacity. Lung function tests revealed restrictive 
patterns in cases 2 and 4. Lung function tests were impossible 
in the other young cases because of non-cooperation.
Although interstitial lung disease has been considered idio-
pathic, factors such as medications, radiation, infections, and 
environmental and occupational agents have been implicated 
in its development.
6-8 Within each of the familial case series 
presented, the patients shared the same environment and ex-
perienced an almost simultaneous onset of similar clinical 
symptoms (Table). The lung biopsy specimens and radiological 
findings in these case series showed a similar pattern across af-
fected family members, suggesting that a common environ-
mental insult or viral infection might have been a causal or trig-
gering factor for the development of interstitial pneumonia with 
lung fibrosis in these patients.
The association between interstitial pneumonia and genetic 
mutations in a family raised the question of whether genetic 
mutation could be responsible for the simultaneous develop-
ment of this disease in family members of different ages. Al-
though genetic susceptibility cannot be ruled out in these fa-
milial cases, the simultaneous development of interstitial pneu-
monia implies the involvement of exposure to common envi-
ronmental factors or the presence of infection in each family 
member. Because all family members reside in an urban region 
with no history of contact with animals or dust, it is suggested 
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that interstitial pneumonia may be associated with viral infec-
tions; however, more investigation is needed in the future.
A nationwide pediatric surveillance study performed in 2006 
and then again in 2008 demonstrated a geographical and sea-
sonal pattern to the increased incidence of unclassified intersti-
tial pneumonia with fibrosis in Korea.
3 Between February and 
June in both 2006 and 2008, an increase in the incidence of un-
classified interstitial pneumonia with fibrosis was initially ob-
served in the southern regions of the country, and this pro-
gressed gradually toward the northern regions.
2,5 The spring 
timing of this interstitial pneumonia, its characteristic pattern 
of spread from the south to north, and the detection of various 
viruses (i.e., human corona virus, cytomegalovirus, and parain-
fluenza virus), when considered together with the findings of 
the present familial case series, provide evidence that viral in-
fection may be associated with the development of unclassified 
interstitial pneumonia with fibrosis in Korea. Altered or exag-
gerated host defense mechanisms, or repair processes triggered 
by a viral infection, may be responsible for the lung damage 
and fibrosis observed in these patients.
Early lung biopsy is indicated in cases of suspected interstitial 
pneumonia. Within 3 weeks of symptom onset, fibroblastic 
proliferation is evident on histological examination, and this 
manifests clinically as rapidly progressing respiratory failure.
6,7 
In Case 1 of the present report, although histological examina-
tion revealed fibroproliferation, this patient experienced a bet-
ter outcome than the other four cases. This better outcome in-
dicates that rapid diagnosis and early therapeutic intervention 
may inhibit disease progression and increase survival in pa-
tients with unclassified interstitial pneumonia with fibrosis.
Although there is no proven effective therapy for unclassified 
interstitial pneumonia with fibrosis, recommended treatments 
include supportive care and immunosuppressive therapies such 
as corticosteroids, cyclophosphamide, and vincristine.
7,10 These 
treatments were found to be most effective during the early 
proliferative phase, i.e., before the development of fibrosis in 
the late fibrotic phase.
9 Early treatment with corticosteroids, cy-
clophosphamide, and hydroxychloroquine, a combination de-
signed to inhibit fibrogenesis, might have contributed to the 
more favorable outcome in Case 1 of the present series. In addi-
tion, the presence of a pneumothorax and/or a pneumomedi-
astinum on chest radiography (case 3) and the severity of the 
respiratory difficulty, both reflecting disease severity, may pre-
dict poor response to treatment.
In summary, this report describes two series of familial cases 
of unclassified interstitial pneumonia with fibrosis, presenting 
rapidly progressing respiratory failure. The occurrence of un-
classified interstitial pneumonia with fibrosis only in spring and 
its familial pattern suggest that the development of this disease 
may be related to exposure to viruses or to common inhaled 
environmental agents. Further studies are needed to better un-
derstand the etiology and pathophysiology of unclassified in-
terstitial pneumonia with fibrosis. As this disease has a poor 
prognosis, early diagnosis with lung biopsy and radiological ex-
amination, and early initiation of immunosuppressive therapy 
are critical for improving the outcome.
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